Skip to main content
Premium Trial:

Request an Annual Quote

A Retraction After No Documentation Found

A PLOS One study from Claude Fauquet's lab at the Donald Danforth Plant Science Center purporting to show that cassava could be genetically modified to express zeolin, transforming the plant into one that could supply protein, has been retracted, reports Ivan Oransky at Retraction Watch.

According to the retraction notice at PLOS One, "the authors have been unable to confirm the presence of the zeolin gene within the transgenic cassava plants in several subsequent studies" and an internal investigation at the Danforth center found that "significant amounts of data and supporting documentation that were claimed to be produced by the first author could not be found." The first author, Mohammad Abhary left the Danforth Center in 2011.

James Carrington, the president of the Danforth, tells Retraction Watch that "this really shined a bright light on the need to document research through processes that were well-known through training, and that could be tracked, whereby data were preserved for periods of time that met national standards."

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.